Postdoctoral Research Associate
Paul Joyce completed his PhD in Pharmacy (UniSA) in 2016, where his contribution to the fields of pharmaceutical science and materials engineering were recognised with the Postgraduate Medal for Most Outstanding Thesis and the Norton Jackson Materials Science and Engineering Highly Commended Award. Upon completing his PhD, Paul was awarded a highly competitive, international Postdoctoral Research Fellowship at Chalmers University of Technology (Gothenburg, Sweden) under the supervision of Prof. Fredrik Höök. Paul’s primary research interests have centralised around understanding the biophysical processes of gastrointestinal digestion for the development of innovative oral drug formulations... Read more
About me
Postdoctoral Research Associate
Paul Joyce completed his PhD in Pharmacy (UniSA) in 2016, where his contribution to the fields of pharmaceutical science and materials engineering were recognised with the Postgraduate Medal for Most Outstanding Thesis and the Norton Jackson Materials Science and Engineering Highly Commended Award. Upon completing his PhD, Paul was awarded a highly competitive, international Postdoctoral Research Fellowship at Chalmers University of Technology (Gothenburg, Sweden) under the supervision of Prof. Fredrik Höök. Paul’s primary research interests have centralised around understanding the biophysical processes of gastrointestinal digestion for the development of innovative oral drug formulations that enhance the bioavailability of challenging therapeutics. Paul has authored 21 journal articles (14 first / lead author) that have been published in leading international journals, 1 international patent and 1 book chapter, and he has presented at over 20 national and international conferences. Paul currently supervisors multiple PhD and Masters students and has an extensive network of academic and industry partners who provide valuable support for his research activities.
About me
About me
Date | Title |
---|---|
14/12/2018 |
Could eating DIRT be the cure for obesity?, https://www.dailymail.co.uk/health/article-6493241/How-pill-mud-cure-obesity-soaking-fat-stop-body-absorbing-it.html |
About me
Doctor of Philosophy University of South Australia
Postdoctoral Research Fellow - Chalmers University of Technology, 2017 - 2019
Doctor of Philosophy (Pharmacy) - University of South Australia, 2012 - 2016
Bachelor of Engineering (Honours) (Pharmaceutical and Chemical) - University of Adelaide, 2007 - 2011
Designing, engineering and applying innovative drug delivery solutions that overcome key biopharmaceutical challenges for the benefit of the wider community. Cutting edge biophysical and synthesis techniques are employed to develop novel strategies and technologies that are well-positioned for rapid clinical translation.
Research
Excludes commercial-in-confidence projects.
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2019 |
13
11
120
|
2019 |
Open access
69
61
4
|
2017 |
21
19
6
|
2016 |
32
31
|
2015 |
30
27
4
|
Year | Output |
---|---|
2024 |
Open access
|
2023 |
Open access
1
64
|
2023 |
Open access
|
2023 |
1
|
2023 |
Open access
3
1
|
2023 |
Open access
41
|
2023 |
|
2023 |
Open access
|
2023 |
Open access
3
4
|
2023 |
1
|
2023 |
Open access
|
2023 |
7
5
|
2023 |
2
6
|
2022 |
2
2
3
|
2022 |
6
4
66
|
2022 |
Open access
6
2
125
|
2022 |
Open access
264
|
2022 |
Open access
3
3
3
|
2022 |
Open access
3
1
335
|
2022 |
Open access
1
1
|
2021 |
Open access
6
3
|
2021 |
Open access
21
15
4
|
2021 |
Open access
3
3
4
|
2021 |
4
4
1
|
2021 |
32
29
11
|
2021 |
Open access
7
7
10
|
2020 |
Open access
6
5
2
|
2020 |
4
3
|
2020 |
18
15
4
|
2020 |
7
6
1
|
2020 |
12
10
|
2020 |
28
24
2
|
2020 |
Open access
6
5
|
2020 |
Open access
11
11
13
|
2019 |
Open access
15
14
|
2019 |
13
11
120
|
2019 |
9
9
2
|
2019 |
Open access
69
61
4
|
2019 |
34
25
|
2018 |
16
13
5
|
2018 |
15
12
7
|
2018 |
21
19
|
2018 |
22
21
2
|
2017 |
Open access
10
9
|
2017 |
21
19
6
|
2017 |
Open access
16
15
|
2016 |
Open access
36
35
|
2016 |
32
31
|
2016 |
31
28
|
2016 |
26
25
1
|
2016 |
30
28
|
2015 |
22
22
|
2015 |
30
27
4
|
2014 |
Open access
49
47
3
|
Patents
Prestidge & Joyce, ‘Novel Drug Delivery Composition Comprising Polymer-Lipid Hybrid Microparticles’ (PCT/AU2016/000080)
Research
Designing, engineering and applying innovative drug delivery solutions that overcome key biopharmaceutical challenges for the benefit of the wider community. Cutting edge biophysical and synthesis techniques are employed to develop novel strategies and technologies that are well-positioned for rapid clinical translation.
Research
Details | Registry | Status |
---|---|---|
Drug delivery composition comprising polymer-lipid hybrid microparticles Prestidge, Clive Allan; Joyce, Paul Matthew |
Australia | Filed |
External engagement & recognition
Organisation | Country |
---|---|
Chalmers University of Technology | SWEDEN |
Glantreo Limited | IRELAND |
Johnson & Johnson | UNITED STATES |
Macquarie University | AUSTRALIA |
Massey University | NEW ZEALAND |
Monash University | AUSTRALIA |
Oulun Yliopisto | FINLAND |
Russian Academy of Sciences | RUSSIAN FEDERATION |
South Australian Health and Medical Research Institute (SAHMRI) | AUSTRALIA |
Umeå University | SWEDEN |
University of Adelaide | AUSTRALIA |
University of Copenhagen | DENMARK |
University of Gothenburg | SWEDEN |
University of New South Wales | AUSTRALIA |
University of Parma | ITALY |
University of South Australia | AUSTRALIA |
Uppsala University | SWEDEN |
Vaxine Pty Ltd | AUSTRALIA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
Chair of Frontiers in Bio-Nano Science 2021ARC Centre of Excellence in Convergent Bio-Nano Science and Technology |
2021 |
ECR RepresentativeAustralasian Society for Biomaterials and Tissue Engineering |
2021 |
MemberAmerican Association of Pharmaceutical Scientists |
2021 |
MemberAustralasian Colloid and Interface Society |
2021 |
MemberControlled Release Society |
2021 |
MemberAustralian Nanotechnology Network (ANN) |
2021 |
MemberEuropean Colloid & Interface Society |
2021 |
Outreach Committee MemberARC Centre of Excellence in Convergent Bio-Nano Science and Technology |
2021 |
STEM Professional in SchoolsCommonwealth Scientific and Industrial Research Organisation (CSIRO) |
2021 |
Topic EditorMembranes |
2021 |
Topic EditorAntibiotics |
2021 |
YourVoice Lung AdvocateLung Foundation Australia |
2021 |
Chair of Frontiers in Bio-Nano Science 2021ARC Centre of Excellence in Convergent Bio-Nano Science and Technology |
2020 |
ECR RepresentativeAustralasian Society for Biomaterials and Tissue Engineering |
2020 |
Keynote LectureRoyal Australian Chemical Institute (RACI) Chemistry Teachers Association |
2020 |
MemberAmerican Association of Pharmaceutical Scientists |
2020 |
MemberAustralasian Colloid and Interface Society |
2020 |
MemberControlled Release Society |
2020 |
MemberAustralian Nanotechnology Network (ANN) |
2020 |
MemberEuropean Colloid & Interface Society |
2020 |
Outreach Committee MemberARC Centre of Excellence in Convergent Bio-Nano Science and Technology |
2020 |
STEM Professional in SchoolsCommonwealth Scientific and Industrial Research Organisation (CSIRO) |
2020 |
Topic EditorMembranes |
2020 |
Topic EditorAntibiotics |
2020 |
YourVoice Lung AdvocateLung Foundation Australia |
2020 |
MemberAustralasian Pharmaceutical Science Association (APSA) |
2019 |
MemberAmerican Association of Pharmaceutical Scientists |
2019 |
MemberAustralasian Colloid and Interface Society |
2019 |
MemberControlled Release Society |
2019 |
MemberAustralian Nanotechnology Network (ANN) |
2019 |
MemberEuropean Colloid & Interface Society |
2019 |
Postdoctoral Research FellowshipAforsk Foundation |
2019 |
STEM Professional in SchoolsCommonwealth Scientific and Industrial Research Organisation (CSIRO) |
2019 |
Topic EditorAntibiotics |
2019 |
Keynote PresentationInternational Conference on Advanced Nano Materials |
2018 |
MemberAustralasian Pharmaceutical Science Association (APSA) |
2018 |
MemberAmerican Association of Pharmaceutical Scientists |
2018 |
MemberAustralasian Colloid and Interface Society |
2018 |
MemberControlled Release Society |
2018 |
MemberEuropean Colloid & Interface Society |
2018 |
Postdoctoral Research FellowshipAforsk Foundation |
2018 |
Best ECR Oral PresentationEuroFed Lipid Conference |
2017 |
Keynote LectureEuropean Colloid and Interface Science Symposium |
2017 |
MemberAmerican Association of Pharmaceutical Scientists |
2017 |
MemberAustralasian Colloid and Interface Society |
2017 |
MemberControlled Release Society |
2017 |
MemberEuropean Colloid & Interface Society |
2017 |
Postdoctoral Research FellowshipAforsk Foundation |
2017 |
MemberAustralasian Colloid and Interface Society |
2016 |
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
110496 - Lipid-based Nanocarrier Enabled Delivery for Improved T-cell Immunotherapy | Current |
110502 - Developing advanced oral delivery formulations for treating leukemia | Current |
111602 - Improving mental health therapies by targeting the gut microbiome | Current |
Conquering antimicrobial resistant Gram-negative bacteria to address unmet clinical needs | Current |
Design of Lipid Nanoparticles (LNPs) for mRNA-Based Cancer Vaccines | Current |
Developing advanced oral delivery systems for antiviral drugs | Current |
Development of a safe biomaterial-based therapy for obesity | Current |
Exploring the impact of formulation design on PUFA pharmacokinetics and biodistribution | Current |
Lipid-based formulations to overcome challenges in oral drugdelivery | Current |
Optimising treatment of haematological malignancies through the development of evidence-based dose individualisation strategies | Current |
Therapeutic targeting of vitamin D catabolism to prevent advanced breast cancer & metastases | Current |
Understanding the Biological Performance of Plant Derived Fats and Proteins - Towards Improved Meat Analogues | Current |
Beyond the gastrointestinal cell layer: replication of the complex oral absorption barrier through enhanced in vitro models for nanoparticulate oral protein delivery | Completed |
Lipid liquid crystalline nanoparticles: a delivery system for antimicrobial photodynamic therapy | Completed |
Overcoming biological barriers in treating intracellular infections using lipid-based nanoparticles | Completed |
Polymer-lipid hybrid microparticles enhance the intracellular uptake and activity of rifampicin against bacterially infected macrophages | Completed |